ISRCTN18055968
Completed
未知
Enhanced patient activation in cancer care transitions –a randomized controlled trial of a tailored eHealth intervention for men with prostate cancer
innaeus University0 sites170 target enrollmentJune 7, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- innaeus University
- Enrollment
- 170
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2019 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/30900999 protocol 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37672332/ (added 07/09/2023) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33529792/ Patient experiences (added 02/02/2024)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Able to speak, read and understand Swedish
- •2\. Able to get a mobile ID for safe handling of information
- •3\. Access to an email address
- •4\. Computer literate
- •5\. Diagnosis of prostate cancer
- •6\. Suitable for surgical treatment
Exclusion Criteria
- •Does not meet inclusion criteria
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Advance care planning in general practiceChronic, life-limiting illnesses (cancer, heart failure, kidney failure, severe COPD, and mild to severe geriatric frailty)Not ApplicableISRCTN12995230Vrije Universiteit Brussel208
Completed
Not Applicable
m-Palliative Care Link: Improving Palliative Care for Late Stage Tanzanian Cancer PatientsCancerNCT03634696Susan Miesfeldt98
Completed
Not Applicable
Patient Activation Through Counseling, Exercise and MobilizationPancreas CancerBiliary Tract CancerNon Small Cell Lung CancerAdvanced CancerNCT03411200Herlev and Gentofte Hospital99
Active, not recruiting
Phase 2
Do Changes in ctDNA Predict Response for Patients With Oesophageal Cancer Receiving DurvalumabOesophageal CancerNCT03653052Simon C Pacey, MD18
Unknown
Not Applicable
Collaborative Network to Take Responsibility for Oral Anticancer TherapyBreast CancerALLLung CancerMelanomaColorectal CancerProstate CancerNCT02861209KU Leuven228